| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.3M | -69.7% |
| SG&A Expense | $5.6M | -38.5% |
| Operating Income | -$6.9M | +48.3% |
| Pre-tax Income | -$7.0M | +45.0% |
| Net Income | -$5.1M | +59.8% |
| EPS (Basic) | -$3.60 | -605.9% |
| EPS (Diluted) | -$3.60 | -605.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.8M | -29.4% |
| Current Assets | $3.2M | -33.1% |
| Total Assets | $4.7M | -17.4% |
| Current Liabilities | $653K | -63.5% |
| Total Liabilities | $653K | -73.4% |
| Stockholders' Equity | $4.1M | +24.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.8M | +39.1% |
| Investing Cash Flow | $1.5M | — |
| Financing Cash Flow | $4.1M | -54.7% |